Xtant Medical Holdings Inc (XTNT): Next-Year EPS Estimate 59.09%
As of 2026-06-16, Xtant Medical Holdings Inc (XTNT) has a next-year EPS growth estimate of 59.09%.
XTNT was first flagged by our screen on 2026-06-10 with a next-year EPS growth estimate of 59.09%. Current-year growth is projected at -103.67%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 59.09%
- EPS growth this year
- -103.67%
- EPS next quarter (est)
- -$0.02
- Last price
- $0.45
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-16 | 59.09% | -103.67% | -$0.02 | $0.45 |
| 2026-06-15 | 59.09% | -103.67% | -$0.02 | $0.45 |
| 2026-06-14 | 59.09% | -103.67% | -$0.02 | $0.44 |
| 2026-06-11 | 59.09% | -103.67% | -$0.02 | $0.43 |
| 2026-06-10 | 59.09% | -103.67% | -$0.02 | $0.44 |
Screen Performance
Aggregate stats across all 1792 tickers our top-EPS-revision screen has flagged over the past 76 days.
- Median return since detection
- +3.6%
- % of tickers in the green
- 57%
- Median return on winners
- +18.8%
- Large revisions captured
- 822
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Xtant Medical Holdings Inc's next-year EPS growth estimate?▾
As of 2026-06-16, Xtant Medical Holdings Inc (XTNT) has a next-year EPS growth estimate of 59.09%, based on analyst consensus.
What sector and industry does Xtant Medical Holdings Inc belong to?▾
Xtant Medical Holdings Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. XTNT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Xtant Medical Holdings Inc (XTNT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports